Product
Toripalimab + Capecitabine
1 clinical trial
3 indications
Indication
Nasopharyngeal CarcinomaIndication
High-Risk CancerIndication
Maintenance TherapyClinical trial
Maintenance Therapy With Toripalimab Combined With Capecitabine Versus Maintenancetherapy With Capecitabine Alone in High-risk Nasopharyngeal Carcinoma: a Multicenter, Prospective, Randomized Phase III Clinical Trial (NPC-ICMB)Status: Recruiting, Estimated PCD: 2029-02-20